Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 36(2): 149-54, 2016 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-27078988

RESUMO

OBJECTIVE: To observe the efficacy and safety of modified Shengma Biejia Decoction (MSBD) combined with CAG program in treating elderly acute myeloid leukemia (AML) patients with yin deficiency toxin stasis syndrome (YDTSS). METHODS: Totally 46 elderly AML patients were assigned to the treatment group (24 cases; treated with MSBD + CAG) and the control group (22 cases; treated with CAG + placebos of Chinese medicine) according to random digit table. The therapeutic course of CM placebo or MSBD was 21 days. The clinical efficacy and adverse reactions were observed. Meanwhile, physical state (ECOG Score), transfusion dependency, and TCM syndrome score were compared before and after treatment. RESULTS: (1) The complete remission rate was 54% (13/24) and the objective response rate (ORR) was 71% (17/24) in the treatment group, obviously higher than those of the control group [36% (8/22); 54% (13/24)], with statistical difference (P = 0.036, 0.042). When comparing the efficacy based on risk level, the moderate and poor ORR was 71% (10/14) and 67% (6/9) in the treatment group, and 57% (8/14) and 33% (2/6) in the control group, with statistical difference between the two groups (P = 0.048; P = 0.010). (2) Compared with before treatment in the same group, the ECOG score significantly decreased, the average infusion time of red cells and platelets were markedly prolonged in the treatment group after treatment (P < 0.05). ECOG score, the average infusion time of red cells and platelets were significantly better in the treatment group than in the control group after treatment (P < 0.05). (3) Compared with before treatment in the same group, scores of fever, hemorrhage, and bone pain were markedly reduced in the control group (P < 0.05); scores of fever, fatigue, hemorrhage, dry mouth, and bone pain were markedly reduced in the treatment group (P < 0.05). Better effect in relief of fever, fatigue, hemorrhage, dry mouth, and so on was obtained in the treatment group than in the control group (P < 0.05). (4) In aspect of hematotoxicity, the incidence of neutropenia, anemia, thrombocytopenia was obviously lower in the treatment group than in the control group [29.2% (7/24) vs 54.5% (12/22); 16.7% (4/ 24) vs 45.5% (10/22); 33.3% (8/24) vs 63.6% (14/22); P < 0.05]. The incidence of fatigue and anorexia was obviously lower in the treatment group than in the control group [37.5% (9/24) vs 63.6% (14/22), 37.5% (9/24) vs 81.8% (18/22); P < 0.05]. CONCLUSION: MSBD combined with CAG program in treating elderly AML patients with YDTSS, with efficacy enhancing toxicity reducing effect, had distinct advantages in improving physical condition and clinical symptoms, and reducing transfusion dependency.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Medicamentos de Ervas Chinesas/uso terapêutico , Leucemia Mieloide Aguda/tratamento farmacológico , Fitoterapia , Deficiência da Energia Yin/tratamento farmacológico , Aclarubicina/uso terapêutico , Idoso , Citarabina/uso terapêutico , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Humanos , Medicina Tradicional Chinesa
2.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 36(1): 108-10, 2016 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-26955689

RESUMO

There is no radical cure for essential thrombocythemia currently. Professor SUN Xue-mei has extensive clinical experience in treating it by combined therapy of Chinese and Western medicine. In this paper, authors tried to summarize her experience from guiding ideology and therapeutic points. Authors insisted on the direction of integrative medicine on the basis of syndrome differentiation, paying attention to psychological counseling,and applied individual treatment in clinics.


Assuntos
Medicina Tradicional Chinesa , Terapia por Acupuntura , Feminino , Humanos , Medicina Integrativa
3.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 36(9): 1132-1134, 2016 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-30645857

RESUMO

Chinese medicine therapy has advantages in treating aplastic anemia (AA) in depart- ments of Chinese medicine (CM) blood diseases. But there is no unified syndrome typing standard of CM for severe AA. Heat-toxin induced yin deficiency syndrome is one of severe AA syndrome types com- monly seen in authors' long-term clinical practice. This syndrome type has the features of asthenia in ori- gin and asthenia in superficiality. Therefore, authors put forward that detoxication, blood activating, and yin nourishing (DBAYN) method, taking detoxication as superficiality and Shen supplementing as origin. Meanwhile, blood activating and stasis removing was assisted. Detoxication aimed to eliminating evils and purifying blood, blood activating aimed to getting rid of evils and generating new blood, and yin nour- ishing aimed to strengthening vital qi and nourishing blood. Classical recipes such as Xijiao Dihuang De- coction and Erzhi Pill could be modified. This theory was of great significance in complementing and per- fecting CM theoretical systems of AA, which provided beneficial ideas and methods for clinical treatment of severe AA.


Assuntos
Anemia Aplástica , Medicina Tradicional Chinesa , Deficiência da Energia Yin , Anemia Aplástica/terapia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA